<DOC>
	<DOCNO>NCT02489682</DOCNO>
	<brief_summary>This study evaluate effectiveness patient-centered short write informed consent form patient-centered short video inform consent randomize control trial ( control = traditional informed consent ) . Primary outcome measure include critical knowledge acquisition , risk benefit judgment , desire enrollment hypothetical clinical trial . The investigator hypothesize patient-centered patient-designed consent form ( video write format ) would well outperform traditional consent form primary outcome .</brief_summary>
	<brief_title>Clinical Informed Consent Format Evaluation</brief_title>
	<detailed_description>Traditional informed consent document tend lengthy technical , often dense facilitate proper patient-engagement . In study , investigator test effectiveness previously develop patient-centered , short inform consent document patient-centered , short inform animated consent video compare lengthy traditional informed consent document clinical condition ( i.e . severe asthma ) In study , self-identified asthma patient , age 18 old , attend experimental session university computer laboratory randomly assign read either full informed consent document ( control ) short , patient-centered informed consent document view short patient-centered informed consent video . Participants also complete follow-up survey 1-week . The main outcome measure : Engagement information ( 1=not engage , 2=not engage , 3= somewhat engage , 4=very engage , 5=completely engage ) . Intention enroll clinical trial ( 1=definitely would , 3=neutral , 5=definitely would ) Trial knowledge ( 12 multiple choice question , e.g . `` `` When [ participant ] withdraw trial ? '' ) Trust clinical trial physician ( Six question begin , `` If [ participant ] decide enroll study , much would [ participant ] trust Dr. Janet Taylor , physician lead study , ... '' ) Perceived risk benefit trial ( Four question , e.g . `` Imagine [ participant ] enrol clinical trial , likely [ participant ] think drug would effective treat [ participant 's ] asthma symptom average asthma drug market ? '' ) The investigator hypothesize two experimental condition outperform control condition engagement trial knowledge would well control remain outcome measure .</detailed_description>
	<criteria>least 18 year age fluent English selfidentifying asthma patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>